Lifecare Neuro Products Profile
Key Indicators
- Authorised Capital ₹ 4.25 Cr
- Paid Up Capital ₹ 2.42 Cr
- Company Age 21 Year, 9 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 32.32 Cr
- Satisfied Charges ₹ 4.30 Cr
- Revenue Growth 6.12%
- Profit Growth 31.25%
- Ebitda 36.17%
- Net Worth 23.30%
- Total Assets 15.18%
About Lifecare Neuro Products
Lifecare Neuro Products Limited (LNPL) is a leading Public Limited Indian Non-Government Company incorporated in India on 13 February 2004 and has a history of 21 years. Its registered office is in Solan, Himachal Pradesh, India.
The Corporate was formerly known as Lifecare Infro Products Limited. The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 4.25 Cr and a paid-up capital of Rs 2.42 Cr.
The company currently has active open charges totaling ₹32.32 Cr. The company has closed loans amounting to ₹4.30 Cr, as per Ministry of Corporate Affairs (MCA) records.
Yogendra Chopra, Ravi Chopra, Madhav Chopra, and One other member serve as directors at the Company.
Company Details
- Location
Solan, Himachal Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24230HP2004PLC010587
- Company No.
026811
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
13 Feb 2004
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Himachal Pradesh
Industry
What products or services does Lifecare Neuro Products Limited offer?
Lifecare Neuro Products Limited offers a wide range of products and services, including Common Disease Medicines, Anti Smoking Drugs, Pharma & Bioanalytical Services, Pharmaceutical Third Party Manufacturing, Pharmaceutical Medicine, Brain & Nervous System Drugs, Antidepressant & Anti Anxiety Medicines, Nutraceuticals & Dietary Supplements, Weight Loss Supplement, Anti Infective Drugs & Medicines.
Who are the key members and board of directors at Lifecare Neuro Products?
Board Members (4)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Madhav Chopra ![]() | Director | 27-Jul-2013 | Current |
Yogendra Chopra ![]() | Director | 13-Feb-2004 | Current |
Ravi Chopra ![]() | Director | 13-Feb-2004 | Current |
Karan Chopra ![]() | Director | 01-Feb-2015 | Current |
Financial Performance of Lifecare Neuro Products.
Lifecare Neuro Products Limited, for the financial year ended 2021, experienced modest growth in revenue, with a 6.12% increase. The company also saw a substantial improvement in profitability, with a 31.25% increase in profit. The company's net worth Soared by an impressive increase of 23.3%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Lifecare Neuro Products?
In 2021, Lifecare Neuro Products had a promoter holding of 45.69% and a public holding of 54.31%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Charges (Loans)
₹32.32 Cr
₹4.30 Cr
Charges Breakdown by Lending Institutions
- State Bank Of India : 25.06 Cr
- Others : 6.18 Cr
- Axis Bank Limited : 1.08 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
11 Jan 2024 | State Bank Of India | ₹3.00 Cr | Open |
28 Sep 2023 | Axis Bank Limited | ₹5.00 M | Open |
07 Feb 2020 | State Bank Of India | ₹22.06 Cr | Open |
30 Dec 2019 | Axis Bank Limited | ₹5.80 M | Open |
17 Dec 2019 | Others | ₹1.80 M | Open |
How Many Employees Work at Lifecare Neuro Products?
Lifecare Neuro Products has a workforce of 149 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Lifecare Neuro Products, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lifecare Neuro Products's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.